Lithium price ticks up in China; Albemarle, SQM climb as earnings near

February 11, 2026
Lithium price ticks up in China; Albemarle, SQM climb as earnings near

New York, Feb 11, 2026, 12:52 PM EST — Regular session

  • Albemarle gained around 3%, while SQM climbed close to 6% in midday trading in New York
  • China’s spot lithium carbonate prices climbed once more, continuing the rebound seen this week
  • Traders are bracing for Albemarle’s earnings report and updated guidance once the market closes

U.S.-listed lithium stocks climbed Wednesday, buoyed by stronger prices in China that drew buyers back into a sector hoping its rebound has legs. Albemarle rose 3.2% to $174.02, Chile’s SQM added 5.8% to $74.36, and Sigma Lithium surged 13.2% to $13.12. Meanwhile, Lithium Americas edged down 1.5% to $4.67.

These shifts matter because lithium prices have been a major factor behind the sector’s earnings struggles over the last two years, pushing miners to tighten budgets and delay projects. When spot prices edge up, stocks usually react quickly—often before those gains appear in contract deals.

Timing plays a key role. Investors want concrete numbers in the upcoming results—specifically, if higher spot prices are translating into realised prices, what producers actually record in sales. They’re also watching to see if executives shift focus from cuts to ramping up volumes.

China’s battery-grade lithium carbonate index climbed to 138,483 yuan per metric ton on Wednesday, with prices for battery-grade material ranging from 134,000 to 142,000 yuan, according to Shanghai Metals Market data. SMM noted that while the most-active lithium carbonate futures contract moved up, physical demand remained weak as downstream buyers wrapped up February stockpiling and logistics slowed down. 1

According to SMM data, the index stood at 134,406 yuan per ton on Tuesday, marking about a 3% increase from the previous day. 2

Some producers are turning to contract setups built for a shaky market. Australia’s PLS Group just secured a new offtake agreement — a supply contract — with China’s Canmax Technologies, locking in a floor price of US$1,000 per ton for spodumene concentrate, the lithium-rich ore used in battery chemicals. The deal also features a US$100 million interest-free prepayment, according to PLS. “The US$100M interest-free prepayment and floor price structure demonstrate strong commercial confidence in our product,” said CEO Dale Henderson. 3

Floor prices aren’t a common feature in the lithium supply chain, and they come with trade-offs. They help miners safeguard their cash flow if prices drop again, but they also highlight just how difficult it’s been for the market to find a “normal” price following the slump.

Albemarle’s quarterly report is set to drop after the New York Stock Exchange closes on Wednesday, with a conference call scheduled for Thursday morning, the company announced. Investors will be watching closely for updates on pricing, costs, and capital expenditures—these will probably have a bigger impact than any minor shifts in spot indices. 4

The physical market remains vulnerable to thin liquidity. If buying slows after restocking while producers continue boosting supply, the recent price gains could stall fast — and lithium stocks often overreact on the way up and down.

Traders will keep an eye on whether Chinese spot prices stay within the current range for the rest of the week and if producers’ comments start reflecting the market’s upbeat mood. Albemarle’s earnings report, due after Wednesday’s close, along with the Feb. 12 call, will be the next major checkpoints for lithium stocks heading into next week.

Stock Market Today

  • Haleon Shares Draw Attention as FTSE 100, FTSE 350 Healthcare React
    March 24, 2026, 2:12 PM EDT. Haleon shares have come under the spotlight amid notable movements in the FTSE 100 and the FTSE 350 healthcare sector. Investors are closely watching the company's performance as it influences broader market sentiment in healthcare stocks. The FTSE 350 healthcare index, representing key players in the sector, is reacting to various factors affecting Haleon and its peers. Market participants are evaluating developments that could impact share prices and sector valuations. This focus highlights the interconnection between individual stock movements and wider index trends in the healthcare space on the London Stock Exchange.